Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 10 studies | 79% ± 12% | |
astrocyte | 9 studies | 33% ± 16% | |
hepatocyte | 5 studies | 60% ± 20% | |
retinal pigment epithelial cell | 3 studies | 33% ± 7% | |
glutamatergic neuron | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipose | 3 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 10726.00 | 258 / 258 | 100% | 16.71 | 229 / 230 |
liver | 100% | 18963.41 | 226 / 226 | 96% | 55.75 | 391 / 406 |
thymus | 96% | 2861.32 | 629 / 653 | 98% | 11.11 | 592 / 605 |
breast | 95% | 21418.87 | 434 / 459 | 98% | 10.84 | 1095 / 1118 |
brain | 91% | 2319.38 | 2402 / 2642 | 100% | 13.11 | 705 / 705 |
uterus | 75% | 967.94 | 128 / 170 | 91% | 5.43 | 419 / 459 |
bladder | 71% | 1296.95 | 15 / 21 | 92% | 5.79 | 465 / 504 |
stomach | 62% | 1057.33 | 222 / 359 | 96% | 6.43 | 274 / 286 |
intestine | 64% | 1177.11 | 614 / 966 | 94% | 5.37 | 493 / 527 |
ovary | 71% | 886.61 | 127 / 180 | 82% | 4.04 | 351 / 430 |
esophagus | 47% | 764.01 | 677 / 1445 | 96% | 6.68 | 175 / 183 |
skin | 50% | 1587.53 | 901 / 1809 | 90% | 7.30 | 427 / 472 |
lung | 40% | 611.36 | 232 / 578 | 97% | 6.81 | 1123 / 1155 |
prostate | 39% | 423.98 | 95 / 245 | 97% | 5.61 | 489 / 502 |
kidney | 36% | 549.02 | 32 / 89 | 88% | 4.74 | 797 / 901 |
pancreas | 30% | 481.69 | 99 / 328 | 86% | 6.62 | 153 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.87 | 1 / 1 |
adipose | 99% | 34129.28 | 1191 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 5.59 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 93% | 10.40 | 74 / 80 |
lymph node | 0% | 0 | 0 / 0 | 90% | 4.67 | 26 / 29 |
heart | 65% | 1394.94 | 556 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 63% | 2498.50 | 840 / 1335 | 0% | 0 | 0 / 0 |
muscle | 63% | 983.52 | 504 / 803 | 0% | 0 | 0 / 0 |
spleen | 49% | 560.63 | 117 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 16% | 221.83 | 145 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042104 | Biological process | positive regulation of activated T cell proliferation |
GO_0055091 | Biological process | phospholipid homeostasis |
GO_0055089 | Biological process | fatty acid homeostasis |
GO_0006072 | Biological process | glycerol-3-phosphate metabolic process |
GO_0009749 | Biological process | response to glucose |
GO_0070236 | Biological process | negative regulation of activation-induced cell death of T cells |
GO_0051607 | Biological process | defense response to virus |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0016024 | Biological process | CDP-diacylglycerol biosynthetic process |
GO_0019432 | Biological process | triglyceride biosynthetic process |
GO_0008654 | Biological process | phospholipid biosynthetic process |
GO_0006637 | Biological process | acyl-CoA metabolic process |
GO_0001817 | Biological process | regulation of cytokine production |
GO_0006924 | Biological process | activation-induced cell death of T cells |
GO_0006651 | Biological process | diacylglycerol biosynthetic process |
GO_0050798 | Biological process | activated T cell proliferation |
GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
GO_0006655 | Biological process | phosphatidylglycerol biosynthetic process |
GO_0040018 | Biological process | positive regulation of multicellular organism growth |
GO_0005886 | Cellular component | plasma membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0004366 | Molecular function | glycerol-3-phosphate O-acyltransferase activity |
GO_0102420 | Molecular function | sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GPAM |
Protein name | Glycerol-3-phosphate acyltransferase 1, mitochondrial (EC 2.3.1.15) Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15) |
Synonyms | GPAT1 hCG_40975 KIAA1560 |
Description | FUNCTION: Esterifies acyl-group from acyl-ACP to the sn-1 position of glycerol-3-phosphate, an essential step in glycerolipids biosynthesis such as triglycerides, phosphatidic acids and lysophosphatidic acids. . FUNCTION: Esterifies acyl-group from acyl-ACP to the sn-1 position of glycerol-3-phosphate, an essential step in glycerolipids biosynthesis such as triglycerides, phosphatidic acids and lysophosphatidic acids. . FUNCTION: Esterifies acyl-group from acyl-ACP to the sn-1 position of glycerol-3-phosphate, an essential step in glycerolipids biosynthesis such as triglycerides, phosphatidic acids and lysophosphatidic acids. . |
Accessions | Q9HCL2 Q5VW52 ENST00000348367.9 ENST00000369425.5 Q8N1G6 |